Literature DB >> 26519023

Inositol-1,4,5-trisphosphate-3-kinase-A controls morphology of hippocampal dendritic spines.

Jan-Dietrich Köster1, Birthe Leggewie1, Christine Blechner1, Nicola Brandt2, Lars Fester2, Gabriele Rune2, Michaela Schweizer3, Stefan Kindler4, Sabine Windhorst5.   

Abstract

Long-lasting synaptic plasticity is often accompanied by morphological changes as well as formation and/or loss of dendritic spines. Since the spine cytoskeleton mainly consists of actin filaments, morphological changes are primarily controlled by actin binding proteins (ABPs). Inositol-1,4,5-trisphosphate-3-kinase-A (ITPKA) is a neuron-specific, actin bundling protein concentrated at dendritic spines. Here, we demonstrate that ITPKA depletion in mice increases the number of hippocampal spine-synapses while reducing average spine length. By employing actin to ABP ratios similar to those occurring at post synaptic densities, in addition to cross-linking actin filaments, ITPKA strongly inhibits Arp2/3-complex induced actin filament branching by displacing the complex from F-actin. In summary, our data show that in vivo ITPKA negatively regulates formation and/or maintenance of synaptic contacts in the mammalian brain. On the molecular level this effect appears to result from the ITPKA-mediated inhibition of Arp2/3-complex F-actin branching activity.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Arp2/3 complex; Cytoskeleton; Drebrin; ITPKA; Neurons; Synaptic plasticity

Mesh:

Substances:

Year:  2015        PMID: 26519023     DOI: 10.1016/j.cellsig.2015.10.016

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  3 in total

Review 1.  Inositol-1,4,5-trisphosphate 3-kinase-A (ITPKA) is frequently over-expressed and functions as an oncogene in several tumor types.

Authors:  Sabine Windhorst; Kai Song; Adi F Gazdar
Journal:  Biochem Pharmacol       Date:  2017-04-02       Impact factor: 5.858

2.  Strong fascin expression promotes metastasis independent of its F-actin bundling activity.

Authors:  Lisa S Heinz; Stefanie Muhs; Johanna Schiewek; Saskia Grüb; Marcus Nalaskowski; Yuan-Na Lin; Harriet Wikman; Leticia Oliveira-Ferrer; Tobias Lange; Jasmin Wellbrock; Anja Konietzny; Marina Mikhaylova; Sabine Windhorst
Journal:  Oncotarget       Date:  2017-11-01

3.  Altered TAOK2 activity causes autism-related neurodevelopmental and cognitive abnormalities through RhoA signaling.

Authors:  Melanie Richter; Nadeem Murtaza; Stephen W Scherer; Karun K Singh; Froylan Calderon de Anda; Robin Scharrenberg; Sean H White; Ole Johanns; Susan Walker; Ryan K C Yuen; Birgit Schwanke; Bianca Bedürftig; Melad Henis; Sarah Scharf; Vanessa Kraus; Ronja Dörk; Jakob Hellmann; Zsuzsa Lindenmaier; Jacob Ellegood; Henrike Hartung; Vickie Kwan; Jan Sedlacik; Jens Fiehler; Michaela Schweizer; Jason P Lerch; Ileana L Hanganu-Opatz; Fabio Morellini
Journal:  Mol Psychiatry       Date:  2018-02-21       Impact factor: 15.992

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.